SCHEMBL24718389

SCHEMBL24718389

Cc1cccc(C(=O)NC2CC(=O)N(Cc3ccccc3C(F)(F)F)C2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ MAPT P10636 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ OPRK1 P41145 1/20 0.44
▸ KCNK3 O14649 1/20 0.44
▸ KCNK9 Q9NPC2 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ P2RX7 Q99572 2/20 0.43
▸ CTDSP1 Q9GZU7 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ ACSS2 Q9NR19 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CYP2C19 P33261 1/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ SIRT1 Q96EB6 1/20 0.40
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718280 0.89 EPHX2 (0.53) TP53ALDH1A1P2RX7ACSS2SIRT2
SCHEMBL24718415 0.85 TP53 (0.49) TP53ALDH1A1NPSR1RAB9AP2RX7
SCHEMBL24718838 0.85 TP53 (0.49) TP53ALDH1A1ALOX12NPSR1RAB9A
SCHEMBL24719111 0.85 EPHX2 (0.47) TP53ALDH1A1P2RX7ACSS2SIRT2
SCHEMBL24719125 0.84 TP53 (0.51) TP53ALDH1A1NPSR1P2RX7TDP1
SCHEMBL24718401 0.83 TP53 (0.50) TP53ALDH1A1NPSR1RAB9ATDP1
SCHEMBL24719126 0.83 EPHX2 (0.42) TP53ALDH1A1P2RX7ACSS2SIRT2
SCHEMBL24718418 0.83 TP53 (0.53) TP53ALDH1A1NPSR1P2RX7TDP1
SCHEMBL24718622 0.83 EPHX2 (0.46) TP53ALDH1A1MAPTRAB9AL3MBTL1
SCHEMBL24718624 0.82 TP53 (0.46) TP53ALDH1A1NPSR1P2RX7TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 TP53 284/4885ALDH1A1 1312/4885MAPT 3453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback